These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12207645)

  • 41. Pharmacogenomics--how close/far are we to practising individualized medicine for children?
    Sing CW; Cheung CL; Wong IC
    Br J Clin Pharmacol; 2015 Mar; 79(3):419-28. PubMed ID: 25855823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An ethical and legal overview of pharmacogenomics: perspectives and issues.
    Sillon G; Joly Y; Feldman S; Avard D
    Med Law; 2008 Dec; 27(4):843-57. PubMed ID: 19202860
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical pharmacogenetics and future prospects in drug therapy].
    Ariyoshi N
    Nihon Yakurigaku Zasshi; 2002 Sep; 120(3):181-6. PubMed ID: 12271513
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improving the power of diagnostics in the era of targeted therapy and personalized healthcare.
    Walk EE
    Curr Opin Drug Discov Devel; 2010 Mar; 13(2):226-34. PubMed ID: 20205056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. From pharmacogenetics to personalized medicine: a vital need for educating health professionals and the community.
    Frueh FW; Gurwitz D
    Pharmacogenomics; 2004 Jul; 5(5):571-9. PubMed ID: 15212593
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ethical issues in developing pharmacogenetic research partnerships with American Indigenous communities.
    Boyer BB; Dillard D; Woodahl EL; Whitener R; Thummel KE; Burke W
    Clin Pharmacol Ther; 2011 Mar; 89(3):343-5. PubMed ID: 21326261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Tasks and expectations for drug design based on pharmacogenomics].
    Uyama Y
    Nihon Yakurigaku Zasshi; 2005 Dec; 126(6):432-5. PubMed ID: 16463462
    [No Abstract]   [Full Text] [Related]  

  • 48. [Pharmacogenetic aspects of current pharmacotherapy].
    Slanar O; Zima T
    Cas Lek Cesk; 2010; 149(10):472-5. PubMed ID: 21121137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. From personalized medicine to personalized justice: the promises of translational pharmacogenomics in the justice system.
    Wong SH; Happy C; Blinka D; Gock S; Jentzen JM; Donald Hon J; Coleman H; Jortani SA; Lucire Y; Morris-Kukoski CL; Neuman MG; Orsulak PJ; Sander T; Wagner MA; Wynn JR; Wu AH; Yeo KT
    Pharmacogenomics; 2010 Jun; 11(6):731-7. PubMed ID: 20504247
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmacogenetics.
    Wolf CR; Smith G
    Br Med Bull; 1999; 55(2):366-86. PubMed ID: 10723863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacogenetics and nicotine addiction treatment.
    Munafò MR; Shields AE; Berrettini WH; Patterson F; Lerman C
    Pharmacogenomics; 2005 Apr; 6(3):211-23. PubMed ID: 16013953
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacogenetics: a general review on progress to date.
    Daly AK
    Br Med Bull; 2017 Dec; 124(1):65-79. PubMed ID: 29040422
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Semantically enabling pharmacogenomic data for the realization of personalized medicine.
    Samwald M; Coulet A; Huerga I; Powers RL; Luciano JS; Freimuth RR; Whipple F; Pichler E; Prud'hommeaux E; Dumontier M; Marshall MS
    Pharmacogenomics; 2012 Jan; 13(2):201-12. PubMed ID: 22256869
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fitting the drug to the patient.
    Mayor S
    BMJ; 2007 Mar; 334(7591):452-3. PubMed ID: 17332583
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacogenetics in diverse ethnic populations--implications for drug discovery and development.
    McCarthy LC; Davies KJ; Campbell DA
    Pharmacogenomics; 2002 Jul; 3(4):493-506. PubMed ID: 12164773
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Applications of pharmacogenomics in regulatory science: a product life cycle review.
    Tan-Koi WC; Leow PC; Teo YY
    Pharmacogenomics J; 2018 May; 18(3):359-366. PubMed ID: 29205206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacogenomics and drug development.
    Guo Y; Shafer S; Weller P; Usuka J; Peltz G
    Pharmacogenomics; 2005 Dec; 6(8):857-64. PubMed ID: 16296948
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug receptor/effector polymorphisms and pharmacogenetics: current status and challenges.
    Johnson JA; Lima JJ
    Pharmacogenetics; 2003 Sep; 13(9):525-34. PubMed ID: 12972951
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Drug discovery based on genomic information].
    Nohmi T
    Rinsho Byori; 2002 Jul; 50(7):694-7. PubMed ID: 12187707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacogenetics in geriatric medicine: challenges and opportunities for clinical practice.
    Pilotto A; Panza F; Seripa D
    Curr Drug Metab; 2011 Sep; 12(7):621-34. PubMed ID: 21495974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.